Literature DB >> 11675411

Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?

Karin Dahan1, Arno Fuchshuber2, Stavroula Adamis1, Michèle Smaers1, Sabine Kroiss2, Guy Loute3, Jean-Pierre Cosyns4, Friedhelm Hildebrandt2, Christine Verellen-Dumoulin1, Yves Pirson5.   

Abstract

Familial juvenile hyperuricemic nephropathy (FJHN) is an autosomal dominant disorder heralded by hyperuricemia during childhood; it is characterized by chronic interstitial nephritis, with marked thickening of tubular basement membranes, and leads to progressive renal failure during adulthood. A gene for FJHN in two Czech families was recently mapped to chromosome 16p11.2, close to the MCKD2 locus, which is responsible for a variant of autosomal dominant medullary cystic kidney disease observed in an Italian family. In a large Belgian family with FJHN, a tight linkage between the disorder and the marker D16S3060, located within the MCKD2 locus on chromosome 16p12 (maximal two-point logarithmic odds score of 3.74 at a recombination fraction of theta = 0), was observed in this study. The candidate region was further narrowed to a 1.3-Mb interval between D16S501 and D16S3036. Together with the striking clinical and pathologic resemblance between previously reported medullary cystic kidney disease type 2 and FJHN occurring in the Belgian family (including the presence of medullary cysts), this study suggests that these two disorders are facets of the same disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675411     DOI: 10.1681/ASN.V12112348

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

Review 1.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

2.  Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.

Authors:  T C Hart; M C Gorry; P S Hart; A S Woodard; Z Shihabi; J Sandhu; B Shirts; L Xu; H Zhu; M M Barmada; A J Bleyer
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

3.  16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development.

Authors:  Meade Haller; Jason Au; Marisol O'Neill; Dolores J Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

Review 4.  From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.

Authors:  Gopalakrishnan Venkat-Raman; Christine Gast; Anthony Marinaki; Lynnette Fairbanks
Journal:  Pediatr Nephrol       Date:  2016-02-12       Impact factor: 3.714

Review 5.  Uromodulin: old friend with new roles in health and disease.

Authors:  Franca M Iorember; V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2013-07-24       Impact factor: 3.714

Review 6.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

7.  Wild-type uromodulin prevents NFkB activation in kidney cells, while mutant uromodulin, causing FJHU nephropathy, does not.

Authors:  Dganit Dinour; Liat Ganon; Levin-Iaina Nomy; Rotem Ron; Eliezer J Holtzman
Journal:  J Nephrol       Date:  2014-03-20       Impact factor: 3.902

8.  Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.

Authors:  Sian E Piret; Patrick Danoy; Karin Dahan; Anita A C Reed; Karena Pryce; William Wong; Rosa J Torres; Juan G Puig; Thomas Müller; Peter Kotanko; Karl Lhotta; Olivier Devuyst; Matthew A Brown; Rajesh V Thakker
Journal:  Hum Genet       Date:  2010-10-26       Impact factor: 4.132

9.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Authors:  Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

10.  Association between genotype and phenotype in uromodulin-associated kidney disease.

Authors:  Jonathan L Moskowitz; Sian E Piret; Karl Lhotta; Thomas M Kitzler; Adam P Tashman; Erin Velez; Rajesh V Thakker; Peter Kotanko
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.